TREA

87425888 - SALUBRISBIO

Follow

Information

  • Trademark
  • 87425888
  • Serial Number
    87425888
  • Registration Number
    5748146
  • Filing Date
    April 26, 2017
    7 years ago
  • Registration Date
    May 14, 2019
    5 years ago
  • Transaction Date
    May 14, 2024
    8 months ago
  • Status Date
    May 14, 2019
    5 years ago
  • Published for Opposition Date
    February 26, 2019
    5 years ago
  • Location Date
    May 14, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEELEY, ALISON REBECCA
  • Attorney Name
    Timothy T. Wang
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
5
Mark Identification
SALUBRISBIO
Case File Statements
  • DM0000: The mark consists of stylized word of "SalubrisBio".
  • GS0051: Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 7/27/2017 - 7 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/29/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/3/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/24/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/27/2017 - 7 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/27/2017 - 7 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/27/2017 - 7 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/27/2017 - 7 years ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/30/2017 - 7 years ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/19/2017 - 7 years ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/19/2017 - 7 years ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/14/2017 - 7 years ago
    12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/14/2018 - 6 years ago
    20 - SOU EXTENSION 1 FILED Type: EXT1
  • 6/18/2018 - 6 years ago
    13 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 6/18/2018 - 6 years ago
    14 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 7/17/2018 - 6 years ago
    15 - TEAS PETITION TO REVIVE RECEIVED Type: PROA
  • 7/17/2018 - 6 years ago
    16 - PETITION TO REVIVE-GRANTED Type: PETG
  • 7/17/2018 - 6 years ago
    17 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX
  • 7/18/2018 - 6 years ago
    18 - NOTICE OF REVIVAL - E-MAILED Type: NREV
  • 9/6/2018 - 6 years ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 9/21/2018 - 6 years ago
    21 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 9/22/2018 - 6 years ago
    22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/5/2018 - 6 years ago
    24 - ASSIGNED TO PETITION STAFF Type: APET
  • 9/24/2018 - 6 years ago
    23 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 10/9/2018 - 6 years ago
    25 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 11/14/2018 - 6 years ago
    30 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 12/17/2018 - 6 years ago
    26 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 12/17/2018 - 6 years ago
    27 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 1/22/2019 - 6 years ago
    28 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/22/2019 - 6 years ago
    29 - REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED Type: RGIA
  • 1/23/2019 - 6 years ago
    31 - 1(B) BASIS DELETED; NEW BASIS REQUESTED Type: ADBS
  • 1/25/2019 - 6 years ago
    32 - NOTICE OF REINSTATEMENT MAILED Type: MREI
  • 2/6/2019 - 5 years ago
    33 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/26/2019 - 5 years ago
    34 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/26/2019 - 5 years ago
    35 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/14/2019 - 5 years ago
    36 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/14/2024 - 8 months ago
    37 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1